Form 4: Gilead EVP Acquires Shares Through Performance Vesting

Gilead Sciences' EVP and General Counsel, Keeley M. Cain Wettan, acquired 470 shares of common stock through the vesting of performance share awards.

Summary

• Keeley M. Cain Wettan, Executive Vice President, General Counsel, Legal & Compliance at Gilead Sciences, Inc. (GILD), acquired 470 shares of the company's common stock.
• The transaction occurred on February 27, 2026, and represents shares from performance share awards granted to the reporting person on March 10, 2025.
• The performance vesting requirement for these specific tranches of shares was satisfied on February 27, 2026, following certification of performance goal attainment by the Compensation and Talent Committee of Gilead's Board of Directors.
• These shares were subject to both performance-vesting and service-vesting requirements.
• Following this acquisition, Keeley M. Cain Wettan beneficially owns a total of 4,414 shares of Gilead Sciences common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event, as it confirms the achievement of performance goals and increases executive alignment, though it is a routine compensation event with minimal direct market impact.

Positives

• The vesting of performance share awards indicates that specific performance goals set by the company's Compensation and Talent Committee were met.
• Increased direct ownership by an executive aligns management's interests more closely with those of shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the completion of a past performance award vesting.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the vesting of performance-based equity awards, are common in the biotechnology and pharmaceutical sectors. These events reflect pre-established compensation structures and the achievement of internal corporate milestones, rather than discretionary open-market purchases or sales.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholders due to higher direct stock ownership, potentially signaling confidence in future performance.

Key Dates

Keywords

Gilead Sciences, GILD, Insider Transaction, Form 4, Performance Share Awards, Executive Compensation, Stock Vesting